NCT00634231View on ClinicalTrials.gov

A Phase I Study of AdV-tk + Prodrug Therapy in Combination With Radiation Therapy for Pediatric Brain Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

December 31, 2015

Study Completion Date

June 30, 2021

Conditions
Malignant GliomaRecurrent Ependymoma
Interventions
BIOLOGICAL

AdV-tk

DRUG

valacyclovir

RADIATION

Radiation

Trial Locations (2)

60611

Ann & Robert H. Lurie Children's Hospital of Chicago (Formerly Children's Memorial Hospital), Chicago

02115

Dana-Farber Cancer Institute, Boston

Sponsors
All Listed Sponsors
collaborator

Boston Children's Hospital

OTHER

lead

Candel Therapeutics, Inc.

INDUSTRY